Literature DB >> 10647900

Genetic susceptibility to pre-eclampsia and chromosome 7q36.

G Guo1, J A Lade, A N Wilton, E K Moses, M Grehan, Y Fu, H Qiu, D W Cooper, S P Brennecke.   

Abstract

Pre-eclampsia is the most common serious medical disorder of human pregnancy. The human endothelial cell nitric oxide synthase (eNOS) gene is a candidate for pre-eclampsia/eclampsia (PE/E) susceptibility. A linkage study was performed on Australian PE/E families using 25 microsatellite markers from chromosome 7, one of which (eNOS-CA) resides within the eNOS gene. No significant linkage was found for the eNOS-CA marker using either parametric or non-parametric analysis. However, D7S 1805 from the eNOS gene region on 7q36, gave a suggestion of linkage using parametric analysis (maximum LOD score =2.143 at theta=0.14) and non-parametric APM analysis (T1/sqrt(p)=3.53; P=0.002). Further, an association study was performed on unrelated PE/E cases and controls from both Chinese and Australian populations to test for a relationship between the eNOS gene and PE/E. No association was found between the eNOS-CA marker and PE/E in either population. However, there was a significant difference in the allelic distribution of eNOS-CA between the two ethnic groups. The linkage results support the possibility that a susceptibility locus for pre-eclampsia resides in the 7q36 region, however, there is no definitive evidence to support the notion that the eNOS gene itself is responsible for susceptibility to pre-eclampsia.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10647900     DOI: 10.1007/s004399900172

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  6 in total

Review 1.  Pathophysiology and maternal biologic markers of preeclampsia.

Authors:  Jacques Massé; Yves Giguère; Abdelaziz Kharfi; Joël Girouard; Jean-Claude Forest
Journal:  Endocrine       Date:  2002-10       Impact factor: 3.633

Review 2.  Endothelial nitric oxide synthase polymorphisms and hypertension.

Authors:  Aroon D Hingorani
Journal:  Curr Hypertens Rep       Date:  2003-02       Impact factor: 5.369

3.  A genome scan in families from Australia and New Zealand confirms the presence of a maternal susceptibility locus for pre-eclampsia, on chromosome 2.

Authors:  E K Moses; J A Lade; G Guo; A N Wilton; M Grehan; K Freed; A Borg; J D Terwilliger; R North; D W Cooper; S P Brennecke
Journal:  Am J Hum Genet       Date:  2000-10-17       Impact factor: 11.043

4.  Genome-wide transcriptome directed pathway analysis of maternal pre-eclampsia susceptibility genes.

Authors:  Hannah E J Yong; Phillip E Melton; Matthew P Johnson; Katy A Freed; Bill Kalionis; Padma Murthi; Shaun P Brennecke; Rosemary J Keogh; Eric K Moses
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

5.  Endothelial nitric oxide synthase gene polymorphism (Glu298Asp) and development of pre-eclampsia: a case-control study and a meta-analysis.

Authors:  Christina K H Yu; Juan P Casas; Makrina D Savvidou; Manpreet K Sahemey; Kypros H Nicolaides; Aroon D Hingorani
Journal:  BMC Pregnancy Childbirth       Date:  2006-03-16       Impact factor: 3.007

6.  eNOS/iNOS and endoplasmic reticulum stress-induced apoptosis in the placentas of patients with preeclampsia.

Authors:  L Du; F He; L Kuang; W Tang; Y Li; D Chen
Journal:  J Hum Hypertens       Date:  2016-03-31       Impact factor: 3.012

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.